Obesity In Prostate Cancer Patients Predicts Cancer Recurrence And Progression
Obesity in a patient is an independent predictor of whether localized prostate cancer will progress following radiotherapy treatment, say researchers at M. D. Anderson Cancer Center.In a study reported in the Aug. 1 issue of the journal Cancer, researchers found that moderately and severely obese patients had a 99 percent greater risk of developing biochemical failure (an early marker of cancer progression) than other patients. [click link for full article]

Shorter, ‘kinder’ radiotherapy for breast cancer patients
Women with breast cancer may soon be able to get shorter 'kinder' radiotherapy treatment, say researchers. Research has shown halving the number of treatments but giving high intensity doses works just as well and could have fewer harmful side effects

Obesity raises recurrence risk of prostate cancer (Reuters)
Reuters - Obese men have an increased risk of cancer recurrence after undergoing treatment with radiotherapy for localized prostate cancer, new research shows.

Herceptin approved for NHS use
Herceptin, the breast cancer 'wonder drug', should be made available to early-stage sufferers on the NHS, the Government's health watchdog has announced. The move - which will come into effect next month - follows the granting of a UK licence for the drug by European authorities

Breast Cancer Risk Increased With Weight Gain In Postmenopausal Women
Weight gain, particularly after menopause, is associated with an increased risk of breast cancer in women, according to an article in the July 12 issue of JAMA.Background information in the article indicates that weight loss after menopause lowers circulating estrogen hormones in women, and because estrogen is directly related to breast cancer, weight loss is thought to decrease risk of the disease. [click link for full article]